UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Effects of Rituximab on Lipids, Arterial Stiffness and Carotid Intima-Media Thickness in Rheumatoid Arthritis

Journal of Korean Medical Science, 2016, 31(2), 211, pp.202-207

2016

Volltextzugriff (PDF)

Morphometry Results of Formed Osteodefects When Using Nanocrystalline CeO2 in the Early Stages of Regeneration

International journal of dentistry, 2019, Vol.2019 (2019), p.1-9

2019

Volltextzugriff (PDF)

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Arthritis research & therapy, 2016-02, Vol.18 (50), p.50-50, Article 50

2016

Volltextzugriff (PDF)

Diffuse Reflectance Spectroscopy of the Oral Mucosa: In Vivo Experimental Validation of the Precancerous Lesions Early Detection Possibility

Diagnostics (Basel), 2023-05, Vol.13 (9), p.1633

2023

Volltextzugriff (PDF)

Experience of anticipatory therapy with IL-6 receptor inhibitors and perspectives for its use in the evolution of COVID-19

Terapevtic̆eskii arhiv, 2022-10, Vol.94 (8), p.1028-1035

2022

Volltextzugriff (PDF)

Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy

Rheumatology international, 2018-02, Vol.38 (2), p.211-217

2018

Volltextzugriff (PDF)

Rituximab Downregulates Gene Expression Associated with Cell Proliferation, Survival, and Proteolysis in the Peripheral Blood from Rheumatoid Arthritis Patients: A Link between High Baseline Autophagy-Related ULK1 Expression and Improved Pain Control

Arthritis, 2016-01, Vol.2016, p.23-34

2016

Volltextzugriff (PDF)

08.33 Treatment of rheumatoid arthritis patients: comparative efficacy of four treatment regimens

Annals of the rheumatic diseases, 2017-03, Vol.76 (Suppl 1), p.A89

2017

Volltextzugriff (PDF)

08.33Treatment of rheumatoid arthritis patients: comparative efficacy of four treatment regimens

Annals of the rheumatic diseases, 2017-03, Vol.76 (Suppl 1), p.A89-A89

2017

Volltextzugriff (PDF)

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Annals of the rheumatic diseases, 2011-09, Vol.70 (9), p.1575-1580

2011

Volltextzugriff (PDF)

After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries

Annals of the rheumatic diseases, 2023-02, Vol.82 (2), p.175-181

2023

Volltextzugriff (PDF)

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

Annals of the rheumatic diseases, 2016-07, Vol.75 (7), p.1336-1342

2016

Volltextzugriff (PDF)

Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis

Seminars in arthritis and rheumatism, 2020-02, Vol.50 (1), p.17-24

2020

Volltextzugriff (PDF)

Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies

Joint, bone, spine : revue du rhumatisme, 2024-03, Vol.91 (2), p.105671-105671, Article 105671

2024

Volltextzugriff (PDF)

Certolizumab pegol in therapy for rheumatoid arthritis

Sovremennai͡a︡ revmatologii͡a, 2012-06 (2), p.44

2012

Volltextzugriff (PDF)

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

Annals of the rheumatic diseases, 2012-03, Vol.71 (3), p.374-377

2012

Volltextzugriff (PDF)

ADVERSE EVENTS OF INFLIXIMAB: FROM PUBLICATION ANALYSIS TO ORIGINAL STUDIES

The Bulletin of Contemporary Clinical Medicine, 2019-01, Vol.12 (1), p.11-18

2019

Volltextzugriff (PDF)

Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration

Journal of rheumatology, 2017-02, Vol.44 (2), p.162-169

2017

Volltextzugriff (PDF)

08.50Anti-destructive effect of rituximab and b-cell count in rheumatoid arthritis patients

Annals of the rheumatic diseases, 2017-03, Vol.76 (Suppl 1), p.A97-A97

2017

Volltextzugriff (PDF)

08.50 Anti-destructive effect of rituximab and b-cell count in rheumatoid arthritis patients

Annals of the rheumatic diseases, 2017-03, Vol.76 (Suppl 1), p.A97

2017

Volltextzugriff (PDF)

06.04 Comparison of abatacept influence on disease activity and functional status in patients with different stages of rheumatoid arthritis

Annals of the rheumatic diseases, 2017-03, Vol.76 (Suppl 1), p.A61

2017

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Englisch
(59)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(28)
Rheumatoid Arthritis
(18)
Rheumatology
(17)
Arthritis, Rheumatoid - Drug Therapy
(12)
Humans
(12)
Antirheumatic Agents - Therapeutic Use
(10)
Female
(10)
Middle Aged
(10)
Treatment Outcome
(10)
Male
(9)
Medicin Och Hälsovetenskap
(9)
Tumor Necrosis Factor-Tnf
(9)
Collaboration
(8)
Patients
(8)
Adult
(7)
Aged
(7)
Registries
(6)
Rituximab
(5)
Antirheumatic Agents
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Effects of Rituximab on Lipids, Arterial Stiffness and Carotid Intima-Media Thickness in Rheumatoid Arthritis

Morphometry Results of Formed Osteodefects When Using Nanocrystalline CeO2 in the Early Stages of Regeneration

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Diffuse Reflectance Spectroscopy of the Oral Mucosa: In Vivo Experimental Validation of the Precancerous Lesions Early Detection Possibility

Experience of anticipatory therapy with IL-6 receptor inhibitors and perspectives for its use in the evolution of COVID-19

Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy

Rituximab Downregulates Gene Expression Associated with Cell Proliferation, Survival, and Proteolysis in the Peripheral Blood from Rheumatoid Arthritis Patients: A Link between High Baseline Autophagy-Related ULK1 Expression and Improved Pain Control

08.33 Treatment of rheumatoid arthritis patients: comparative efficacy of four treatment regimens

08.33Treatment of rheumatoid arthritis patients: comparative efficacy of four treatment regimens

Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration

The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study)

Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis

Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies

Certolizumab pegol in therapy for rheumatoid arthritis

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

ADVERSE EVENTS OF INFLIXIMAB: FROM PUBLICATION ANALYSIS TO ORIGINAL STUDIES

Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration

08.50Anti-destructive effect of rituximab and b-cell count in rheumatoid arthritis patients

08.50 Anti-destructive effect of rituximab and b-cell count in rheumatoid arthritis patients

06.04 Comparison of abatacept influence on disease activity and functional status in patients with different stages of rheumatoid arthritis

Suchergebnisse filtern